An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease.

Publication: J Neurol

Underwood BR, Green-Thompson ZW, Pugh PJ, Lazic SE, Mason SL4, Griffin J, Jones PS, Rowe JB, Rubinsztein DC7,4, Barker RA.

26 October 2017

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025